News & Events


Health Policy Open
Variation in Medicaid and commercial coverage of cell and gene therapies
Health Affairs Forefront
The Case For Including Dynamic Drug Pricing In Cost-Effectiveness Analyses Under The IRA
The American Journal of Managed Care
Varied Use of Step Therapy Among Medicare Advantage Plans
The Milbank Quarterly
Improving Food and Drug Administration–Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval
Cost Effectiveness and Resource Allocation
Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol
The New England Journal of Medicine
Turning CMS into a health technology assessment organization
JAMA Network Open
Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act
Journal of Market Access & Health Policy
Rule of Prevention: a potential framework to evaluate preventive interventions for rare diseases
Health Affairs Scholar
Commercial Coverage of Specialty Drugs 2017-2021